Literature DB >> 1389840

Synergistic interaction between midazolam and propofol.

S McClune1, A C McKay, P M Wright, C C Patterson, R S Clarke.   

Abstract

We gave either midazolam or propofol for induction of anaesthesia to 140 ASA I or II female patients (18-60 yr). ED50 values were obtained by probit analysis for three clinical end-points: loss of response to command; loss of eyelash reflex; failure to respond to application of an anaesthetic face mask delivering 1% isoflurane. Propofol ED50 values (95% confidence intervals) were 1.25 (0.99-1.48) mg kg-1, 1.61 (1.29-1.94) mg kg-1 and 1.51 (1.20-1.82) mg kg-1, respectively. ED50 values for midazolam were 0.26 (0.20-0.37) mg kg-1, 0.29 (0.23-0.47) mg kg-1 and 0.25 (0.20-0.32) mg kg-1, respectively. An additional 92 similar patients received one of nine dose combinations of midazolam and propofol for induction of anaesthesia, propofol being administered 2 min after midazolam. Success of induction was based on the clinical end-point of loss of response to command. Administration of 25% of the ED50 of midazolam followed by 50% of the ED50 of propofol resulted in loss of response to command in 50% of patients, while 50% of the ED50 of midazolam, followed by 25% of the ED50 of propofol had the same effect. A probit regression model specifying a synergistic interaction between midazolam and propofol fitted the data significantly better than a model specifying no interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389840     DOI: 10.1093/bja/69.3.240

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  17 in total

1.  Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution.

Authors:  Jun Ohmori; Shigeru Maeda; Hitoshi Higuchi; Minako Ishii; Yukiko Arai; Yumiko Tomoyasu; Atsushi Kohjitani; Masahiko Shimada; Takuya Miyawaki
Journal:  J Anesth       Date:  2011-06-01       Impact factor: 2.078

2.  The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.

Authors:  Daniel J Shin; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-08-08       Impact factor: 4.436

3.  Midazolam and awareness with recall during total intravenous anaesthesia.

Authors:  D R Miller; P G Blew; R J Martineau; K A Hull
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

4.  Robust control of burst suppression for medical coma.

Authors:  M Brandon Westover; Seong-Eun Kim; ShiNung Ching; Patrick L Purdon; Emery N Brown
Journal:  J Neural Eng       Date:  2015-05-28       Impact factor: 5.379

5.  Efficacy and safety of a patient-positioning device (EZ-FIX) for endoscopic retrograde cholangiopancreatography.

Authors:  Seungho Lee; Joung-Ho Han; Hee Seung Lee; Ki Bae Kim; In-Kwang Lee; Eun-Jong Cha; Young Duck Shin; Namgyu Park; Seon Mee Park
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

6.  A Comparative Study of Propofol and Isoflurane Anaesthesia using Butorphanol in Neurosurgery.

Authors:  Ld Mishra; N Rajkumar; Sn Singh; Rk Dubey; G Yadav
Journal:  Indian J Anaesth       Date:  2009-06

7.  Midazolam coinduction does not delay discharge after very brief propofol anaesthesia.

Authors:  T Elwood; S Huchcroft; C MacAdams
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

8.  Recovery characteristics following induction of anaesthesia with a combination of thiopentone and propofol.

Authors:  S Rashiq; B Gallant; M Grace; D T Jolly
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

9.  A comparative study of efficacy of propofol auto-co-induction versus midazolam propofol co-induction using the priming principle.

Authors:  Roopam Kataria; Ajay Singhal; Sukirti Prakash; Ishwar Singh
Journal:  Indian J Anaesth       Date:  2010-11

10.  Comparison of midazolam alone versus midazolam plus propofol during endoscopic submucosal dissection.

Authors:  Young Shim Cho; Euikeun Seo; Jung-Ho Han; Soon Man Yoon; Hee Bok Chae; Seon Mee Park; Sei Jin Youn
Journal:  Clin Endosc       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.